ME3183

· Meiji Pharma USA Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ME3183, covering 2024-06-27 to 2024-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]